136 related articles for article (PubMed ID: 9761942)
21. Inserting chromosome 18 into pancreatic cancer cells switches them to a dormant metastatic phenotype.
Lefter LP; Sunamura M; Furukawa T; Takeda K; Kotobuki N; Oshimura M; Matsuno S; Horii A
Clin Cancer Res; 2003 Oct; 9(13):5044-52. PubMed ID: 14581380
[TBL] [Abstract][Full Text] [Related]
22. Gabexate mesilate inhibits colon cancer growth, invasion, and metastasis by reducing matrix metalloproteinases and angiogenesis.
Yoon WH; Jung YJ; Kim TD; Li G; Park BJ; Kim JY; Lee YC; Kim JM; Park JI; Park HD; No ZS; Lim K; Hwang BD; Kim YS
Clin Cancer Res; 2004 Jul; 10(13):4517-26. PubMed ID: 15240544
[TBL] [Abstract][Full Text] [Related]
23. Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression.
Salcedo R; Ponce ML; Young HA; Wasserman K; Ward JM; Kleinman HK; Oppenheim JJ; Murphy WJ
Blood; 2000 Jul; 96(1):34-40. PubMed ID: 10891427
[TBL] [Abstract][Full Text] [Related]
24. The tetrapeptide AcSDKP, an inhibitor of primitive hematopoietic cell proliferation, induces angiogenesis in vitro and in vivo.
Liu JM; Lawrence F; Kovacevic M; Bignon J; Papadimitriou E; Lallemand JY; Katsoris P; Potier P; Fromes Y; Wdzieczak-Bakala J
Blood; 2003 Apr; 101(8):3014-20. PubMed ID: 12480715
[TBL] [Abstract][Full Text] [Related]
25. Role of human cripto-1 in tumor angiogenesis.
Bianco C; Strizzi L; Ebert A; Chang C; Rehman A; Normanno N; Guedez L; Salloum R; Ginsburg E; Sun Y; Khan N; Hirota M; Wallace-Jones B; Wechselberger C; Vonderhaar BK; Tosato G; Stetler-Stevenson WG; Sanicola M; Salomon DS
J Natl Cancer Inst; 2005 Jan; 97(2):132-41. PubMed ID: 15657343
[TBL] [Abstract][Full Text] [Related]
26. Characterization of TNP-470-induced modifications to cell functions in HUVEC and cancer cells.
Farinelle S; Malonne H; Chaboteaux C; Decaestecker C; Dedecker R; Gras T; Darro F; Fontaine J; Atassi G; Kiss R
J Pharmacol Toxicol Methods; 2000; 43(1):15-24. PubMed ID: 11091126
[TBL] [Abstract][Full Text] [Related]
27. Characterization of gastrin-induced proangiogenic effects in vivo in orthotopic U373 experimental human glioblastomas and in vitro in human umbilical vein endothelial cells.
Lefranc F; Mijatovic T; Mathieu V; Rorive S; Decaestecker C; Debeir O; Brotchi J; Van Ham P; Salmon I; Kiss R
Clin Cancer Res; 2004 Dec; 10(24):8250-65. PubMed ID: 15623601
[TBL] [Abstract][Full Text] [Related]
28. A new in vitro assay for quantitating tumor cell invasion.
Repesh LA
Invasion Metastasis; 1989; 9(3):192-208. PubMed ID: 2722434
[TBL] [Abstract][Full Text] [Related]
29. Inhibitors of basement membrane collagen synthesis prevent endothelial cell alignment in matrigel in vitro and angiogenesis in vivo.
Haralabopoulos GC; Grant DS; Kleinman HK; Lelkes PI; Papaioannou SP; Maragoudakis ME
Lab Invest; 1994 Oct; 71(4):575-82. PubMed ID: 7526036
[TBL] [Abstract][Full Text] [Related]
30. Interaction of endothelial cells with a laminin A chain peptide (SIKVAV) in vitro and induction of angiogenic behavior in vivo.
Grant DS; Kinsella JL; Fridman R; Auerbach R; Piasecki BA; Yamada Y; Zain M; Kleinman HK
J Cell Physiol; 1992 Dec; 153(3):614-25. PubMed ID: 1280280
[TBL] [Abstract][Full Text] [Related]
31. In vivo vasculogenic potential of human blood-derived endothelial progenitor cells.
Melero-Martin JM; Khan ZA; Picard A; Wu X; Paruchuri S; Bischoff J
Blood; 2007 Jun; 109(11):4761-8. PubMed ID: 17327403
[TBL] [Abstract][Full Text] [Related]
32. Distinct antitumor properties of a type IV collagen domain derived from basement membrane.
Maeshima Y; Colorado PC; Torre A; Holthaus KA; Grunkemeyer JA; Ericksen MB; Hopfer H; Xiao Y; Stillman IE; Kalluri R
J Biol Chem; 2000 Jul; 275(28):21340-8. PubMed ID: 10766752
[TBL] [Abstract][Full Text] [Related]
33. Defibrotide: an endothelium protecting and stabilizing drug, has an anti-angiogenic potential in vitro and in vivo.
Koehl GE; Geissler EK; Iacobelli M; Frei C; Burger V; Haffner S; Holler E; Andreesen R; Schlitt HJ; Eissner G
Cancer Biol Ther; 2007 May; 6(5):686-90. PubMed ID: 17495522
[TBL] [Abstract][Full Text] [Related]
34. Adenoviral vectors expressing human endostatin-angiostatin and soluble Tie2: enhanced suppression of tumor growth and antiangiogenic effects in a prostate tumor model.
Raikwar SP; Temm CJ; Raikwar NS; Kao C; Molitoris BA; Gardner TA
Mol Ther; 2005 Dec; 12(6):1091-100. PubMed ID: 16169279
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of programmed cell death impairs in vitro vascular-like structure formation and reduces in vivo angiogenesis.
Segura I; Serrano A; De Buitrago GG; González MA; Abad JL; Clavería C; Gómez L; Bernad A; Martínez-A C; Riese HH
FASEB J; 2002 Jun; 16(8):833-41. PubMed ID: 12039865
[TBL] [Abstract][Full Text] [Related]
36. The HUVEC/Matrigel assay: an in vivo assay of human angiogenesis suitable for drug validation.
Skovseth DK; Küchler AM; Haraldsen G
Methods Mol Biol; 2007; 360():253-68. PubMed ID: 17172733
[TBL] [Abstract][Full Text] [Related]
37. Interaction with endothelial cells is a prerequisite for branching ductal-alveolar morphogenesis and hyperplasia of preneoplastic human breast epithelial cells: regulation by estrogen.
Shekhar MP; Werdell J; Tait L
Cancer Res; 2000 Jan; 60(2):439-49. PubMed ID: 10667599
[TBL] [Abstract][Full Text] [Related]
38. DNAzymes to beta 1 and beta 3 mRNA down-regulate expression of the targeted integrins and inhibit endothelial cell capillary tube formation in fibrin and matrigel.
Cieslak M; Niewiarowska J; Nawrot M; Koziolkiewicz M; Stec WJ; Cierniewski CS
J Biol Chem; 2002 Mar; 277(9):6779-87. PubMed ID: 11675378
[TBL] [Abstract][Full Text] [Related]
39. Tumor cell invasion assays.
Shaw LM
Methods Mol Biol; 2005; 294():97-105. PubMed ID: 15576908
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of tumor angiogenesis by roxithromycin, a 14-membered ring macrolide antibiotic.
Yatsunami J; Tsuruta N; Hara N; Hayashi S
Cancer Lett; 1998 Sep; 131(2):137-43. PubMed ID: 9851245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
